{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:34:03Z","timestamp":1791282843215,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["LR18H300002"],"award-info":[{"award-number":["LR18H300002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31671022"],"award-info":[{"award-number":["31671022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ijpharm.2018.09.017","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T03:04:10Z","timestamp":1536635050000},"page":"164-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prevention of corneal neovascularization by subconjunctival injection of avastin\u00ae loaded thermosensitive hydrogels in rabbit model"],"prefix":"10.1016","volume":"552","author":[{"given":"Xu","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0368-4538","authenticated-orcid":false,"given":"Xingyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2018.09.017_b0005","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","article-title":"A comprehensive insight on ocular pharmacokinetics","volume":"6","author":"Agrahari","year":"2016","journal-title":"Drug Deliv. Transl. Re."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0010","first-page":"18","article-title":"Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization","volume":"39","author":"Amano","year":"1998","journal-title":"Invest Ophth. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0015","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","article-title":"Corneal avascularity is due to soluble VEGF receptor-1","volume":"443","author":"Ambati","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/ICO.0b013e318159019f","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization","volume":"27","author":"Bahar","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0025","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/17425247.5.5.567","article-title":"Ocular novel drug delivery: impacts of membranes and barriers","volume":"5","author":"Barar","year":"2008","journal-title":"Expert Opin. Drug Del."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0030","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/jama.1963.03060110088027","article-title":"Elevated intraocular pressure following corticosteroid eye drops","volume":"185","author":"Becker","year":"1963","journal-title":"JAMA"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0035","first-page":"94","article-title":"Corneal neovascularization: clinical aspects and the role of the immune system","author":"Bonini","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jconrel.2007.05.009","article-title":"Poly (N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery","volume":"120","author":"Cao","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0045","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0050","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ejpb.2011.11.013","article-title":"Stimuli-Responsive Hydrogels for Controlled Pilocarpine Ocular Delivery","volume":"80","author":"Casolaro","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.exer.2004.04.008","article-title":"Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization","volume":"79","author":"Castro","year":"2004","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0060","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0065","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv. Ophthalmol."},{"issue":"940\u2013948","key":"10.1016\/j.ijpharm.2018.09.017_b0070","article-title":"Short-term topical bevacizumab in the treatment of stable corneal neovascularization","volume":"154","author":"Cheng","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0075","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s004170100313","article-title":"Impact of short-term versus long-term topical steroids on corneal neovascularization after non-high-risk keratoplasty","volume":"239","author":"Cursiefen","year":"2001","journal-title":"Graef Arch. Clin. Exp."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0080","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00702-013-0986-0","article-title":"Lack of association between VAP-1\/SSAO activity and corneal neovascularization in a rabbit model","volume":"120","author":"\u00c9nzs\u00f6ly","year":"2013","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0085","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/ICO.0b013e3182775f8d","article-title":"Topical ranibizumab as a treatment of corneal neovascularization","volume":"32","author":"Ferrari","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0090","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00003226-200307000-00018","article-title":"Photodynamic therapy of corneal neovascularization with verteporfin","volume":"22","author":"Fossarello","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0095","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0100","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","article-title":"Recent perspectives in ocular drug delivery","volume":"26","author":"Gaudana","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijpharm.2008.08.027","article-title":"Synthesis and characterization of PEG-PCL-PEG thermosensitive hydrogel","volume":"365","author":"Gong","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0110","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1016\/j.actbio.2009.05.025","article-title":"Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel. Part 2: Sol-Gel-Sol transition and drug delivery behavior","volume":"5","author":"Gong","year":"2009","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0115","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1002\/jps.21694","article-title":"Thermosensitive PEG-PCL-PEG hydrogel controlled drug delivery system: sol-gel-sol transition and in vitro drug release study","volume":"98","author":"Gong","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0120","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/ICO.0b013e318201405a","article-title":"Treatments for corneal neovascularization: a review","volume":"30","author":"Gupta","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0125","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000224783","article-title":"Prevention and treatment of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with corticosteroid in experimental rats","volume":"42","author":"Hashemian","year":"2009","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0130","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0140-6736(15)01088-0","article-title":"Antiangiogenic therapy in oncology: current status and future directions","volume":"388","author":"Jayson","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0135","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/ICO.0000000000000007","article-title":"Comparative study of ranibizumab and bevacizumab on corneal neovascularization in rabbits","volume":"33","author":"Kim","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0140","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/ICO.0000000000001016","article-title":"Effects of combined photodynamic therapy and topical bevacizumab treatment on corneal neovascularization in rabbits","volume":"35","author":"Kim","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0145","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","article-title":"The effect of topical bevacizumab on corneal neovascularization","volume":"115","author":"Kim","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0150","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/ICO.0b013e31815cf67d","article-title":"Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin)","volume":"27","author":"Kim","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0155","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/ICO.0b013e31823f8f7a","article-title":"Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs","volume":"31","author":"Koenig","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/emm.2006.21","article-title":"Inhibition of corneal neovascularization by rapamycin","volume":"38","author":"Kwon","year":"2006","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0165","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review","volume":"43","author":"Lee","year":"1998","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0170","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mabi.201100419","article-title":"Nanomaterials for ocular drug delivery","volume":"12","author":"Liu","year":"2012","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0175","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/02713683.2017.1416146","article-title":"Corneal Neovascularization: A Combined Approach of Bevacizumab and Suramin Showed Increased Antiangiogenic Effect Through Downregulation of BFGF and PX","volume":"43","author":"Lopez","year":"2018","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/10717544.2014.903535","article-title":"Thermosensitive PEG-PCL-PEG (PECE) hydrogel as an in situ gelling system for ocular drug delivery of diclofenac sodium","volume":"23","author":"Luo","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00417-005-0036-1","article-title":"Inhibitory effect of triamcinolone acetonide on corneal neovascularization","volume":"244","author":"Murata","year":"2006","journal-title":"Graef Arch. Clin. Exp."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0190","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1167\/iovs.08-3148","article-title":"Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits","volume":"50","author":"Nomoto","year":"2009","journal-title":"Invest Ophth. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0195","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2015.01.009","article-title":"Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats","volume":"201","author":"Pan","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0200","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest Ophth. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0205","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/med.21452","article-title":"Tumor angiogenesis revisited: Regulators and clinical implications","volume":"37","author":"Ronca","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0210","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.tips.2017.05.004","article-title":"Therapeutic Potential of Ranibizumab in Corneal Neovascularization","volume":"38","author":"Shahsuvaryan","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0215","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ejpb.2006.12.003","article-title":"Swelling, erosion and release behavior of alginate-based matrix tablets","volume":"66","author":"Sriamornsak","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/ICO.0000000000000683","article-title":"Corneal Indocyanine Green Angiography to Guide Medical and Surgical Management of Corneal Neovascularization","volume":"35","author":"Steger","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0225","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.steroids.2017.11.002","article-title":"Glucocorticoid receptor signaling in the eye","volume":"133","author":"Sulaiman","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/jop.1987.3.43","article-title":"Effects of steroidal and non-steroidal anti-inflammatory agents on corneal wound healing","volume":"3","author":"Waterbury","year":"1987","journal-title":"J. Ocul. Pharmacol. Th."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0235","doi-asserted-by":"crossref","DOI":"10.1002\/jbm.a.35467","article-title":"Hyaluronic acid-based nanocomposite hydrogels for ocular drug delivery applications","volume":"103","author":"Widjaja","year":"2015","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ijpharm.2018.09.017_b0240","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijpharm.2015.05.071","article-title":"An injectable thermosensitive polymeric hydrogel for sustained release of Avastin\u00ae to treat posterior segment disease","volume":"490","author":"Xie","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0245","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1076\/ceyr.19.4.300.5301","article-title":"The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat","volume":"19","author":"Yamada","year":"1999","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0250","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0420.2007.01049.x","article-title":"Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn","volume":"86","author":"Yoeruek","year":"2008","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0255","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/02713680600559564","article-title":"Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin","volume":"31","author":"Yoon","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijpharm.2018.09.017_b0260","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/nn506599f","article-title":"Ocular drug delivery nanowafer with enhanced therapeutic efficacy","volume":"9","author":"Yuan","year":"2015","journal-title":"ACS Nano"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318306689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318306689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T04:24:29Z","timestamp":1540268669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517318306689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":52,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0378517318306689"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.09.017","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of corneal neovascularization by subconjunctival injection of avastin\u00ae loaded thermosensitive hydrogels in rabbit model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}